YUM-46495-22726 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-04
Dose 1 — Pfizer-BioNTech
2021-01-22
Dose 2 — Pfizer-BioNTech
2021-01-25
Registered in v-safe
2021-01-25
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-26
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Headache · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-26
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-02-07
Survey response — 14 day, dose 2
MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-07
Report sent to call center — 14 day, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-04	Pfizer-BioNTech
2	2021-01-22	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-26	Unsuccessful
2021-02-07	Unsuccessful

Free text

Release 2

Systemic reaction (other): Lymphadenopathy moderate

Systemic reaction (other): Lymphadenopathy severe

Release 3

Symptoms: Miscarriage

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release